Novel indolyl aryl sulfones active against HIV-1 carrying NNRTI resistance mutations: synthesis and SAR studies
- PMID: 12773052
- DOI: 10.1021/jm0211063
Novel indolyl aryl sulfones active against HIV-1 carrying NNRTI resistance mutations: synthesis and SAR studies
Abstract
The potent anti-HIV-1 activities of L-737,126 (2) and PAS sulfones prompted us to design and test against HIV-1 in acutely infected MT-4 cells a number of novel 1- and 3-benzenesulfonylindoles. Indoles belonging to the 1-benzenesulfonyl series were found poorly or totally inactive. On the contrary, some of the 3-benzenesulfonyl derivatives turned out to be as potent as 2, being endowed with potencies in the low nanomolar concentration range. In particular, (2-methylphenyl)sulfonyl (72) and (3-methylphenyl)sulfonyl (73) derivatives showed EC(50) values of 1 nM. Introduction of two methyl groups at positions 3 and 5 of the phenyl ring of 2 furnished derivatives (80 and 83) which showed very potent and selective anti-HIV-1 activity not only against the wt strain, but also against mutants carrying NNRTI-resistant mutations at positions 103 and 181 of the reverse transcriptase gene.
Similar articles
-
Indolylarylsulfones, a fascinating story of highly potent human immunodeficiency virus type 1 non-nucleoside reverse transcriptase inhibitors.Antivir Chem Chemother. 2018 Jan-Dec;26:2040206617753443. doi: 10.1177/2040206617753443. Antivir Chem Chemother. 2018. PMID: 29417826 Free PMC article. Review.
-
Indolyl aryl sulfones as HIV-1 non-nucleoside reverse transcriptase inhibitors: role of two halogen atoms at the indole ring in developing new analogues with improved antiviral activity.J Med Chem. 2007 Oct 4;50(20):5034-8. doi: 10.1021/jm070488f. Epub 2007 Sep 6. J Med Chem. 2007. PMID: 17803291
-
Simple, short peptide derivatives of a sulfonylindolecarboxamide (L-737,126) active in vitro against HIV-1 wild type and variants carrying non-nucleoside reverse transcriptase inhibitor resistance mutations.J Med Chem. 2004 Jul 15;47(15):3892-6. doi: 10.1021/jm031147e. J Med Chem. 2004. PMID: 15239667
-
Design, molecular modeling, synthesis, and anti-HIV-1 activity of new indolyl aryl sulfones. Novel derivatives of the indole-2-carboxamide.J Med Chem. 2006 Jun 1;49(11):3172-84. doi: 10.1021/jm0512490. J Med Chem. 2006. PMID: 16722636
-
Developments of indoles as anti-HIV-1 inhibitors.Curr Pharm Des. 2009;15(18):2120-48. doi: 10.2174/138161209788489168. Curr Pharm Des. 2009. PMID: 19519449 Review.
Cited by
-
N-Pyrrylarylsulfones with High Therapeutic Potential.Molecules. 2017 Mar 9;22(3):434. doi: 10.3390/molecules22030434. Molecules. 2017. PMID: 28282943 Free PMC article. Review.
-
Synthesis and Bioactivity Evaluation of N-Arylsulfonylindole Analogs Bearing a Rhodanine Moiety as Antibacterial Agents.Molecules. 2017 Jun 14;22(6):970. doi: 10.3390/molecules22060970. Molecules. 2017. PMID: 28613234 Free PMC article.
-
Indolylarylsulfones, a fascinating story of highly potent human immunodeficiency virus type 1 non-nucleoside reverse transcriptase inhibitors.Antivir Chem Chemother. 2018 Jan-Dec;26:2040206617753443. doi: 10.1177/2040206617753443. Antivir Chem Chemother. 2018. PMID: 29417826 Free PMC article. Review.
-
Novel Cyclopropyl-Indole Derivatives as HIV Non-Nucleoside Reverse Transcriptase Inhibitors.ACS Med Chem Lett. 2012 May 2;3(6):470-5. doi: 10.1021/ml3000462. eCollection 2012 Jun 14. ACS Med Chem Lett. 2012. PMID: 24900496 Free PMC article.
-
High potency of indolyl aryl sulfone nonnucleoside inhibitors towards drug-resistant human immunodeficiency virus type 1 reverse transcriptase mutants is due to selective targeting of different mechanistic forms of the enzyme.Antimicrob Agents Chemother. 2005 Nov;49(11):4546-54. doi: 10.1128/AAC.49.11.4546-4554.2005. Antimicrob Agents Chemother. 2005. PMID: 16251294 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Chemical Information
Medical
Miscellaneous